喀什妇科诊疗喀什那所医院妇科好,巴楚哪家妇科医院比较好啊,叶城品牌妇科医院,喀什女性无痛引产的价格,泽普治妇科去哪家医院,喀什妇科喀什哪个医院好,伽师那个不孕不育医院好??

SUVA, Dec. 18 (Xinhua) -- There are 60 typhoid cases in Nanoko, with 29 already hospitalized, according to Fiji's Health Ministry.Senior Health Inspector Paula Laqere said Sunday that the increas means that people are not practicing proper hygiene standards. Laqere said most of the communities in Fiji have a really low level of good hygiene practices.The other problem is that some communities in Fiji have very poor sources of clean and safe water and this is what Fijian guests need to be cautious of."Typhoid is basically spread through contaminated water and our hygiene practices. It's an indicator that the sanitation level of any community is really low."A 30 day public health emergency is in place for the village, effective from Dec. 12 to Jan. 12.Recently, Fiji recorded rates of high typhoid fever in the world, said WHO South Pacific Communicable Disease Surveillance and Response Team leader doctor Jacob Kool.Kool said typhoid fever was difficult to diagnose and could be fatal in 10-20 percent of untreated patients.Recent studies showed that infants are commonly affected and are extremely vulnerable to the disease. Outbreaks occur regularly in areas with poor hygiene and sanitation including urban slums, he said.Kool said the only reliable symptom was prolonged fever and blood and stool culture are still the best available diagnostic tests but have a high rate of false negative results. He said therefore suspected typhoid cases should be treated regardless of the result of lab tests and ciprofloxacin was the recommended therapy for all age groups.Last year AusAID, WHO and UNICEF launched a typhoid fever vaccination campaign in Fiji.

PARIS, Oct. 1 (Xinhua) -- People come to the French capital will be able to enjoy a new public service by leasing electric cars in the urban region from Sunday.This car-sharing system is aimed to reduce the number of private cars as well as restrain pollution, according to the Paris municipal government.The plan, dubbed "the Autolib" system, is similar to already functioning "velib system" which is a large-scale public bicycle sharing system in Paris launched in 2007.The first experimental stage of the Autolib project is said to last two month with 66 cars at 33 stations around the city.Costumers can pay between 5 euros and 7 euros (6.7-9.4 U.S. dollars) for every half-hour use or register for a yearly, weekly or 24-hour package with different cost and necessary identity cards, driving licences and an uncashed deposit.Once fully charged, the four-seated "Bluecar" can reach a top speed of 130 km an hour and has a range of 250 km with a single charge.In order to encourage short journey rather than long trip around the capital, Paris administration wants to expand the system to a 250-car team by this December, and then to 2,000 by next summer.

WASHINGTON, Dec. 21 (Xinhua) -- New research suggests that, in people who don't currently have memory problems, those with smaller regions of the brain's cortex may be more likely to develop symptoms consistent with very early Alzheimer's disease.The study was published Wednesday in the online issue of Neurology, the medical journal of the American Academy of Neurology.For the study, researchers used brain scans to measure the thickness of regions of the brain's cortex in 159 people free of dementia with an average age of 76. The brain regions were chosen based on prior studies showing that they shrink in patients with Alzheimer's dementia.Of the 159 people, 19 were classified as at high risk for having early Alzheimer's disease due to smaller size of particular regions known to be vulnerable to Alzheimer's in the brain's cortex, 116 were classified as average risk and 24 as low risk. At the beginning of the study, participants were also given tests that measured memory, problem solving and ability to plan and pay attention. The tests will go on over the next three yearsThe study found that 21 percent of those at high risk experienced cognitive decline during three years of follow-up after the MRI scan, compared to seven percent of those at average risk and none of those at low risk."Further research is needed on how using MRI scans to measure the size of different brain regions in combination with other tests may help identify people at the greatest risk of developing early Alzheimer's as early as possible," said study author Bradford Dickerson, of Massachusetts General Hospital in Boston and a member of the American Academy of Neurology.

WASHINGTON, Oct. 3 (Xinhua) -- Researchers at St. Michael's Hospital in Canada have discovered a new function for an enzyme that may protect against organ injury and death from anemia, according to a study appearing Monday in the U.S. journal of the Proceeding of the National Academy of Sciences.Researchers found that when people have anemia, neuronal nitric oxide synthase (nNOS) -- an enzyme in nerve cells that produces nitric oxide, an important signaling molecule in the body -- increases the body's ability to respond, adapt to low oxygen levels and makes the body more efficient in delivering oxygen to tissues. They also found that levels of nNOS in the brain increased in anemic mice, and that the mice without this enzyme die earlier, and with higher hemoglobin levels."Identifying this mechanism may lead to new therapies and approaches to improving outcomes for anemic patients," said Dr. Greg Hare, a researcher at the Li Ka Shing Knowledge Institute of the hospital and one of the lead investigators of the study.Anemia occurs when blood has a lower than normal number of red blood cells or hemoglobin -- an iron-rich protein that carries oxygen from the lungs and heart to the rest of the body. Cells need oxygen to survive and to produce energy for all bodily functions. The condition has many different causes including infection (malaria, HIV, parasites), nutritional deficiencies (iron, folate, B12), genetic mutations, pregnancy, trauma and surgical blood loss."This research will help us identify when an anemic patient is at greatest risk for injury and death when undergoing surgery," said Hare. "Research is underway to test these findings in humans."